Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.

SPRB Insider Trading (Spruce Biosciences)

Insider Ownership Percentage: 5.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Spruce Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Spruce Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Spruce Biosciences Share Price & Price History

Current Price: $1.35
Price Change: +0.30 (1.20%)
As of 05/20/2022 01:00 AM ET

This chart shows the closing price history over time for SPRB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.

Spruce Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2021Camilla V. SimpsonDirectorSell334$15.29$5,106.86334View SEC Filing Icon  
5/19/2021Holdings A/S NovoMajor ShareholderSell475,000$13.90$6,602,500.004,514,336View SEC Filing Icon  
4/30/2021Camilla V. SimpsonDirectorSell14,045$16.14$226,686.3014,045View SEC Filing Icon  
10/14/2020Bali MuralidharDirectorBuy200,000$15.00$3,000,000.00View SEC Filing Icon  
10/14/2020Venture Fund Iii L RivervestMajor ShareholderBuy250,000$15.00$3,750,000.004,739,336View SEC Filing Icon  
See Full Table
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

SEC Filings (Institutional Ownership Changes) for Spruce Biosciences (NASDAQ:SPRB)

83.07% of Spruce Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SPRB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Spruce Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022Goldman Sachs Group Inc.42,668$85K0.0%-81.5%0.182%Search for SEC Filing on Google Icon
5/16/2022State Street Corp205,459$0.41M0.0%+61.8%0.875%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC111,700$0.23M0.0%+180.7%0.475%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.153,736$0.31M0.0%-58.7%0.654%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.529,554$1.06M0.0%+26.0%2.254%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp116,501$0.23M0.0%+317.7%0.496%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.230,801$1.03M0.0%+1,681.4%0.984%Search for SEC Filing on Google Icon
2/16/2022Parametric Portfolio Associates LLC64,628$0.29M0.0%N/A0.275%Search for SEC Filing on Google Icon
2/15/2022Susquehanna International Group LLP27,306$0.12M0.0%N/A0.116%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC40,589$0.18M0.0%N/A0.173%Search for SEC Filing on Google Icon
2/14/2022Citadel Advisors LLC1,727,101$7.70M0.0%+1.5%7.361%Search for SEC Filing on Google Icon
2/14/2022Squarepoint Ops LLC13,593$61K0.0%N/A0.058%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.230,801$1.03M0.0%+1,681.4%0.984%Search for SEC Filing on Google Icon
2/14/2022Nuveen Asset Management LLC11,643$29K0.0%-49.4%0.050%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC142,469$0.64M0.0%+27.9%0.607%Search for SEC Filing on Google Icon
2/11/2022Renaissance Technologies LLC39,800$0.18M0.0%+17.1%0.170%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.118,367$0.53M0.0%-5.7%0.504%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC71,756$0.32M0.0%N/A0.306%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE83,104$0.37M0.0%+394.1%0.354%Search for SEC Filing on Google Icon
1/19/2022Marquette Asset Management LLC40,853$0.18M0.0%N/A0.174%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP19,200$0.12M0.0%N/A0.082%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP29,392$0.18M0.0%+145.4%0.126%Search for SEC Filing on Google Icon
11/16/2021Laurion Capital Management LP11,337$68K0.0%-24.2%0.048%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC38,622$0.23M0.0%+124.3%0.165%Search for SEC Filing on Google Icon
11/15/2021Deerfield Management Company L.P. Series C2,200,000$13.22M0.3%+7.5%9.411%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System4,640$28K0.0%-61.4%0.020%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP1,617,601$9.72M0.2%+0.8%6.919%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley75,911$0.46M0.0%-38.1%0.325%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP27,546$0.17M0.0%-70.2%0.118%Search for SEC Filing on Google Icon
11/12/2021Trexquant Investment LP11,998$72K0.0%N/A0.051%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC34,000$0.20M0.0%N/A0.145%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC111,417$0.67M0.0%-13.3%0.477%Search for SEC Filing on Google Icon
11/10/2021Granite Point Capital Management L.P.63,614$0.38M0.0%-36.4%0.272%Search for SEC Filing on Google Icon
11/8/2021State Board of Administration of Florida Retirement System17,440$0.11M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/4/2021Sands Capital Ventures LLC787,007$4.73M0.7%N/A3.366%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley122,590$1.38M0.0%+257.5%0.524%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN7,034$79K0.0%+223.6%0.030%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC17,216$0.19M0.0%-76.4%0.074%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP92,412$1.04M0.0%N/A0.395%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE7,853$88K0.0%-39.0%0.034%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System12,006$0.14M0.0%+14.0%0.051%Search for SEC Filing on Google Icon
8/16/2021Alyeska Investment Group L.P.19,413$0.22M0.0%N/A0.083%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley122,590$1.38M0.0%+257.5%0.524%Search for SEC Filing on Google Icon
8/16/2021State Street Corp124,918$1.40M0.0%+31.8%0.534%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC29,616$0.33M0.0%+159.3%0.127%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.10,770$0.12M0.0%-13.5%0.046%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp77,864$0.87M0.0%+2.3%0.334%Search for SEC Filing on Google Icon
8/13/2021Laurion Capital Management LP14,957$0.17M0.0%-25.2%0.064%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC128,546$1.44M0.0%+17.3%0.551%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.369,520$4.14M0.0%+96.0%1.584%Search for SEC Filing on Google Icon
8/13/2021FMR LLC1,185,673$13.29M0.0%-0.8%5.082%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.163,857$1.84M0.0%-9.0%0.702%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp25,566$0.29M0.0%+33.3%0.110%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.419,789$4.71M0.0%+21.6%1.799%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC73,081$1.21M0.0%-41.4%0.313%Search for SEC Filing on Google Icon
5/18/2021PFM Health Sciences LP489,631$8.13M0.2%-7.5%2.099%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley34,292$0.57M0.0%+543.5%0.147%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC1,702,805$28.27M0.0%+0.1%7.299%Search for SEC Filing on Google Icon
5/17/2021Rock Springs Capital Management LP1,579,301$26.22M0.6%-3.2%6.769%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC11,422$0.19M0.0%-49.6%0.049%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.12,447$0.21M0.0%N/A0.053%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG23,899$0.40M0.0%-7.1%0.103%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp19,180$0.32M0.0%+42.2%0.082%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp76,144$1.26M0.0%-3.9%0.327%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC109,547$1.82M0.0%-6.8%0.470%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.180,023$2.99M0.0%-4.7%0.773%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund6,000$100K0.0%+87.5%0.026%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.345,306$5.73M0.0%+4.0%1.482%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio2,400$39K0.0%+41.2%0.010%Search for SEC Filing on Google Icon
2/19/2021PFM Health Sciences LP529,311$12.87M0.5%N/A2.280%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.188,827$4.59M0.0%N/A0.813%Search for SEC Filing on Google Icon
2/17/2021Sands Capital Management LLC787,007$19.13M0.0%N/A3.390%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC22,666$0.55M0.0%N/A0.098%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.40,352$0.98M0.0%N/A0.174%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.4,050$98K0.0%N/A0.017%Search for SEC Filing on Google Icon
2/12/2021Caas Capital Management LP10,000$0.24M0.0%N/A0.043%Search for SEC Filing on Google Icon
2/12/2021Laurion Capital Management LP20,000$0.49M0.0%N/A0.086%Search for SEC Filing on Google Icon
2/12/2021AWM Investment Company Inc.40,000$0.97M0.1%N/A0.172%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG25,713$0.63M0.0%N/A0.111%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp79,204$1.93M0.0%N/A0.341%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.1,282$31K0.0%N/A0.006%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN3,724$90K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp13,492$0.33M0.0%N/A0.058%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund3,200$78K0.0%N/A0.014%Search for SEC Filing on Google Icon
2/6/2021Granite Point Capital Management L.P.100,000$2.43M0.1%N/A0.431%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.332,032$8.07M0.0%N/A1.430%Search for SEC Filing on Google Icon
2/4/2021Aisling Capital Management LP1,205,511$29.31M5.0%N/A5.193%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Spruce Biosciences logo
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California.
Read More on Spruce Biosciences

Today's Range

Now: $1.35
Low: $1.29
High: $1.40

50 Day Range

MA: $1.87
Low: $1.28
High: $2.23

52 Week Range

Now: $1.35
Low: $1.25
High: $15.52

Volume

207,139 shs

Average Volume

103,843 shs

Market Capitalization

$31.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.48

Who are the company insiders with the largest holdings of Spruce Biosciences?

Spruce Biosciences' top insider investors include:
  1. Venture Fund Iii L Rivervest (Major Shareholder)
  2. Holdings A/S Novo (Major Shareholder)
  3. Camilla V Simpson (Director)
  4. Bali Muralidhar (Director)
Learn More about top insider investors at Spruce Biosciences.

Who are the major institutional investors of Spruce Biosciences?

Spruce Biosciences' top institutional shareholders include:
  1. BlackRock Inc. — 2.25%
  2. State Street Corp — 0.87%
  3. Vanguard Group Inc. — 0.65%
  4. Bank of New York Mellon Corp — 0.50%
  5. Renaissance Technologies LLC — 0.48%
  6. Goldman Sachs Group Inc. — 0.18%
Learn More about top institutional investors of Spruce Biosciences stock.

Which institutional investors are selling Spruce Biosciences stock?

During the last quarter, SPRB stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. Goldman Sachs Group Inc.

Which institutional investors are buying Spruce Biosciences stock?

Within the last quarter, SPRB stock was purchased by institutional investors including:
  1. BlackRock Inc.
  2. Bank of New York Mellon Corp
  3. State Street Corp
  4. Renaissance Technologies LLC
Within the last year, these company insiders have bought Spruce Biosciences stock:
  1. Venture Fund Iii L Rivervest (Major Shareholder)
  2. Holdings A/S Novo (Major Shareholder)
Learn More investors buying Spruce Biosciences stock.
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.